Patent · US Active

Mcl-1 antagonists

US10040780B2 · kind B2 · utility

1Cited by
3References
34Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 3, 2015
Grant dateAug 7, 2018
Priority date—
Expiry dateMar 3, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are Mcl-1 antagonist compositions and methods of treating g the compositions described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.